Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy, showing preliminary signs of efficacy with no serious adverse events linked to the treatment.

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficacy in a phase 1 trial. The ...

MUHLENBERG TWP., Pa. - Amazon appears to be preparing not one but two massive buildings in Berks County to join the company's vast network of fulfillment centers, and it didn't come about because of ...

Since the Internet is filled with hackers and cyber criminals keen on hacking networks for valuable information, ethical hackers are in huge demand and being hired by almost every industry to help ...

China's National Computer Virus Emergency Response Center (CVERC) has doubled down on claims that the threat actor known as Volt Typhoon is a fabrication of the U.S. and its allies. The agency, in ...